“…For example, the mitochondrial antiviral signaling protein (MAVS) [Cao et al, 2016;Sun et al, 2016], which acts as a common adaptor molecule for RIG-I-like receptors that include melanoma differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology 2 proteins (LGP2; Figure 2), is also known as adaptor protein interferon-b (IFNb) promoter stimulator 1 [Onomoto et al, 2014], virusinduced signaling adaptor protein (VISA) [Xu et al, 2005], and CARD adaptor inducing IFN-b (Cardif) [Meylan et al, 2005;Cao et al, 2016;Liu et al, 2016a;Xing et al, 2016]. Nonetheless, in addition to MAVS, several studies have implicated signaling pathways involving cellular nuclear factor kappaB (NF-jB) [Cao et al, 2016;Jha et al, 2016;Liu et al, 2016a] and the stimulator of IFN genes (STING, also known as MITA/ ERIS/MPYS [Onomoto et al, 2014;Liu et al, 2016c]) [Paludan et al, 2011;White et al, 2014;Weinberg et al, 2015;Barrat et al, 2016;Cherry et al, 2016], as well as nuclear factor (erythroid-derived 2)-like 2 (Nrf2) [Gjyshi et al, 2015;Morris et al, 2016]. Proapoptotic proteins, including B-cell lymphoma-associated protein 2 (BCL2)-associated X protein (BAX) [Ohta and Nishiyama, 2011;Weinberg et al, 2015;Gross, 2016;Sun et al, 2016;Thomas and Gale, 2016], are also essential players in mounting a defense.…”